Clinical trial
Targeted-cell Therapy Using Epithelial Stem Cells and Patients' Cardiomyocytes Loaded in Amnion Bilayer to Regenerate Myocardial Infarction Post COVID-19 Complication
NCT04728906 is registered in ClinicalTrials.gov with Rumah Sakit Pusat Angkatan Darat Gatot Soebroto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted-cell Therapy Using Epithelial Stem Cells and Patients' Cardiomyocytes Loaded in Amnion Bilayer to Regenerate Myocardial Infarction Post COVID-19 Complication
- Lead sponsor
- Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2022
- Completion date
- September 1, 2022
- Enrollment
- 10 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.